Track Sanofi's net income ($6.8B) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Loading...
Loading...
As of the most recent data (June 2026), SNYNF shows a net income of $6.8B. That compares with $9.1B in the prior-year period — down 25.9% year over year. That is below the Healthcare sector average of $16B. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, SNYNF's net income is now $6.8B (was $9.1B) — a 25.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Sanofi is outperforming or lagging.
The Healthcare sector average net income is about $16B. Sanofi is at $6.8B, which is lower that average. That is roughly 58.8% below the sector mean. Use the comparison chart on this page to see how SNYNF stacks up against individual peers as well.
Tracking SNYNF's net income over time shows whether Sanofi is scaling, shrinking, or reshaping that part of the business. The current reading is $6.8B That compares with $9.1B in the prior-year period — down 25.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this net income page, Stockcircle has Sanofi's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net income (currently $6.8B) with ownership activity and broader fundamentals.